US dollars and Treasurys are selling off as President Donald Trump's trade war increases risk for American assets. Investors ...

Macro uncertainty and turmoil triggered by tariffs have significantly impacted several growth stocks. However, the current sell-off presents an ...

Asian markets are down despite Trump's tariff pause, ending a brief relief rally. Investors remain wary due to ongoing ...

The 2025 whitepaper from License Global highlights the brand licensing agents that are facilitating consumer product growth ...

Since Donald Trump’s election win in November last year, Lockheed Martin stock (LMT) has been on a gradual descent, drifting ...

Turning to Wall Street, analysts have a Moderate Buy consensus rating on PYPL stock based on 16 Buys and 15 Holds ...

Palantir has been through the wringer lately. The AI darling that once soared to dizzying heights has been experiencing ups ...

Crushon AI supports real-time, emotionally adaptive chat with deep memory and customizable personalities. Whether you’re building a unique AI Girlfriend, exploring fantasy dialogue, or looking for a ...

Roth Capital analyst Jonathan Aschoff reiterated a Buy rating and $20 price target on GeoVax Labs (GOVX) after U.S. HHS Secretary Robert F.

The Trump administration is proceeding toward a possible delisting of Chinese public company shares on U.S. exchanges, Fox Business Network’s ...

Barclays lowered the firm’s price target on TD Synnex (SNX) to $118 from $125 and keeps an Equal Weight rating on the shares after attending ...

Novartis (NVS) announced a planned $23B investment over five years in U.S.-based infrastructure, ensuring all key Novartis medicines for U.S.